⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Complosome (Intracellular Complement)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-09 — Canonical complement C3a-C3AR1 signalling in ageing and age-related disease: Cellular mechanisms, tissue-specific effects and translational challenges.: cross-connection with c3a-c3ar1-complement-signalling: Extracellular canonical C3a–C3AR1 axis pairs with the previously logged intracellular complosome (intC3/intC5) framing to give two complementary complement-based inputs into inflammaging and cell-intrinsic aging biology. (novelty: 3)
- 2026-07-29 — Complosome as a key modulator of cellular senescence, aging and age-related diseases.: 2026 review synthesizes intracellular complement (intC3/intC5, the ‘complosome’) as a cross-cutting modulator of cellular senescence and multiple aging hallmarks via crosstalk with mTOR, NF-κB, and AMPK, and nominates it as a candidate target for age-related disease — conceptual synthesis, no new primary aging data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Complosome as a key modulator of cellular senescence, aging and age-related diseases.
29-jul-2026
novelty 3
per-area 3
strengthens